China Life Insurance (02628) has an accumulated original insurance premium income of approximately 671.7 billion yuan in 2024, representing a year-on-year growth of 4.7%.

10/01/2025

GMT Eight

China Life Insurance (02628) announced that the company's total original insurance premium income during the period from January 1, 2024 to December 31, 2024 was approximately RMB 671.7 billion, representing a year-on-year growth of 4.7%.

JW THERAP-B(02126): BeiNoda has been granted breakthrough therapy designation in China for the treatment of second-line recurrent or refractory adult large B-cell lymphoma.

YUE DA INTL(00629): Ji Hulin has been appointed as the Chairman of the Board.

Contact: contact@gmteight.com

China Life Insurance (02628) has an accumulated original insurance premium income of approximately 671.7 billion yuan in 2024, representing a year-on-year growth of 4.7%.

RECOMMEND

Trump 2.0 policies are coming! Tariffs and deregulation are fueling investment fever in the energy, technology, and financial sectors.

US Stock Market Move | The United States plans to tighten regulations on the export of AI chips, causing AMD Semiconductor (AMD.US) to fall nearly 5%.

US Stock Market Move | UBS raised its target price for Snap Inc. (SNAP.US), and the stock rose more than 7% against the market trend.